{
  "id": 223473,
  "title": "The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings",
  "url": "https://urgent.news/2026/08/06/the-divide-between-eli-lilly-and-novo-nordisk-is-widening-after-their-223473",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-06T13:45:29.000Z",
  "source": {
    "name": "CNBC World",
    "slug": "cnbc-world",
    "url": "https://www.cnbc.com/2026/08/06/eli-lilly-novo-nordisk-earnings-glp1-market.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "CNBC World",
        "title": "Novo Nordisk stock falls after raised forecast fails to change the debate over its obesity business",
        "url": "https://urgent.news/2026/08/05/novo-nordisk-stock-falls-after-raised-forecast-fails-to-change-the",
        "published": "2026-08-05T07:06:14.000Z"
      },
      {
        "outlet": "Fortune",
        "title": "Weight-loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult",
        "url": "https://urgent.news/2026/08/06/weight-loss-drug-wegovy-made-novo-nordisk-europes-most-valuable",
        "published": "2026-08-06T12:31:05.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}